19 october 2017 ahfs ahfs pmi content updates no responses the october update to the ahfs patient medication information pmi database has been published highlights of the update include new pmi monographs fosaprepitant injection emend r fosaprepitant injection is used along with other medications to prevent nausea and vomiting in adults that may occur within 24 hours after . 19 january 2017 ahfs approvals no responses fda approves trulance for chronic idiopathic constipation the us food and drug administration today approved trulance plecanatide for the treatment of chronic idiopathic constipation cic in adult patients no one medication works for all patients suffering from chronic gastrointestinal disorders said julie beitz md director of . Ashp 4500 east west highway suite 900 bethesda maryland 20814 phone 1 866 279 0681 email custservashporg. On march 28 the us food and drug administration approved ocrevus ocrelizumab to treat adult patients with relapsing forms of multiple sclerosis ms and primary progressive multiple sclerosis ppms this is the first drug approved by the fda for ppms ocrevus is an intravenous infusion given by a health care professional. 24 may 2017 ahfs ahfs pmi content updates no responses the may update to the ahfs patient medication information pmi database has been published highlights of the update include new pmi monographs ribociclib kisqali r ribociclib is used in combination with another medication to treat a certain type of hormone receptor positive advanced breast cancer breast cancer that depends